Genpact Limited (G) - Q1 2025 10-Q Summary
Business Context and Reporting Period
This filing covers the quarterly period ended March 31, 2025. Genpact Limited is a global advanced technology services and solutions company with over 145,000 employees serving clients in more than 35 countries. The company operates through three reportable segments: Financial Services, Consumer and Healthcare, and High Tech and Manufacturing.
Key Financial Metrics
| Metric | Q1 2025 | Q1 2024 |
|---|---|---|
| Net Revenues | $1,214.9 million | $1,131.2 million |
| Gross Profit | $429.0 million | $396.5 million |
| Gross Margin | 35.3% | 35.0% |
| Income from Operations | $183.7 million | $160.0 million |
| Operating Margin | 15.1% | 14.1% |
| Net Income | $130.9 million | $116.9 million |
| Diluted EPS | $0.73 | $0.64 |
| Operating Cash Flow | $40.4 million | ($25.6 million) |
| Cash and Equivalents | $561.6 million | $648.2 million (Dec 31, 2024) |
| Total Debt (Current + Long-term) | $1,215.3 million | $1,221.4 million (Dec 31, 2024) |
Material Changes vs. Prior Period
- Revenue Growth: Net revenues increased 7.4% year-over-year (8.3% on a constant currency basis). Growth was driven by an 11.1% increase in Data-Tech-AI services and a 4.2% increase in Digital Operations.
- Profitability: Operating income rose 14.8% to $183.7 million, aided by improved operating leverage and a 30 basis point increase in gross margin.
- Expense Management: SG&A expenses increased 2.6% but decreased as a percentage of revenue from 20.8% to 19.8%. Amortization of acquired intangible assets dropped 37.6% due to the completion of useful lives for prior assets.
- Headcount: Average headcount increased 9.5% to approximately 142,900.
- Cash Flow: Operating cash flow swung from a use of $25.6 million in Q1 2024 to a provision of $40.4 million in Q1 2025, driven by higher net income and improved working capital management (specifically lower accounts receivable balances).
Guidance, Outlook, and Risks
Capital Allocation: The Board approved an 11% increase in the quarterly dividend to $0.17 per share. The company also authorized an additional $500 million for share repurchases, bringing the total program authorization to $2.75 billion. In Q1 2025, the company repurchased 1.2 million shares for approximately $63 million.
Outlook & Risks: Management notes increased macroeconomic uncertainty due to shifting trade policies, tariffs, and geopolitical tensions (including conflicts in the Middle East and between India and Pakistan). While these have not yet materially impacted operations, they pose risks to sales cycles and client spending. The company is actively monitoring the India-Pakistan situation and has implemented contingency plans.
Unusual Items: Q1 2024 included a $5.5 million gain from the redemption of a loan note and a vendor liability waiver, which were not present in Q1 2025, contributing to the variance in "Other operating (income) expense, net."
Investor Verification Checklist
- Constant Currency Growth: Verify the 8.3% constant currency revenue growth rate to understand organic performance excluding FX impacts.
- Stock-Based Compensation: Note the significant increase in stock-based compensation expense ($20.0 million in Q1 2025 vs. $9.2 million in Q1 2024) and its impact on future cash flow and dilution.
- Debt Covenants: Confirm continued compliance with the 2022 Credit Agreement covenants (Net Debt/EBITDA < 3x; Interest Coverage > 3x), which restrict dividend payments if breached.
- Geopolitical Exposure: Assess the potential impact of India-Pakistan tensions on delivery operations, given the company's significant footprint in India.
- Deferred Tax Liabilities: Review the $111.7 million of retained earnings in non-Bermuda subsidiaries for which deferred tax liabilities have been accrued upon repatriation.